Xiao-Zhen Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiao-Zhen Jiang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bin Zhou
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publicationsLin-Yan Xu
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publicationsPei-Li Gu
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publicationsRui-Hua Chen
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publicationsYu-Feng Zou
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publicationsZhe Gu
Department of endocrinology, Pudong New Area People's Hospital, 490, South Chuan Huan Road, Shanghai, China
2 shared publications
Latest Publications
- 1 September 2014
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 75 (4) , 206-212
Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai
- 1 September 2014
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 75 (4) , 206-212
Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai
- 28 August 2013
- Published by Springer Nature in Endocrine
- Vol. 45 (2) , 319-324
Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults
Hypovitaminosis D is highly prevalent in type 2 diabetes. The aim of this study is to determine the serum levels of 25-hydroxyvitamin D [25(OH)D] in type 2 diabetic patients with and without mild cognitive impairment (MCI), and examine the relationship of 25(OH)D and MCI with other clinical factors. One hundred and sixty-five diabetic patients were enrolled in this study. Among whom, 95 patients were considered as MCI [Montreal Cognitive Assessment score (MoCA) < 26] and the other 70 as no MCI (MoCA ≥ 26). Subjects were assessed clinically. Diabetic patients with MCI had a longer duration of DM, fewer years of education, elevated fasting blood glucose (FBG), resistant index (RI) of carotid, and lower levels of 25(OH)D {[17.35 (13.02–25.92) vs 28.00 (19.67–34.30)] ng/ml, P < 0.001}. The MoCA score was positively correlated with log10[25(OH)D], education year, and inversely correlated with duration of DM, history of hypertension, intima-media thickness (IMT), FBG, max-RI, and min-RI. Log10[25(OH)D] was positively correlated with MoCA score, and inversely correlated with IMT, in multivariate regression analysis adjusted for age, sex, and education year, 25(OH)D (β = 0.210, P = 0.003), history of hypertension (β = −0.191, P = 0.007), IMT (β = −0.194, P = 0.007), and FBG (β = −0.157, P = 0.026) independently predicted MoCA score. In conclusion, our results suggest that levels of serum 25(OH)D are inversely associated with the cognitive impairment in diabetic patients. Vitamin D may be a potential protective factor for cognitive impairment in patients with type 2 diabetes.
- 28 August 2013
- Published by Springer Nature in Endocrine
- Vol. 45 (2) , 319-324
Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults
Hypovitaminosis D is highly prevalent in type 2 diabetes. The aim of this study is to determine the serum levels of 25-hydroxyvitamin D [25(OH)D] in type 2 diabetic patients with and without mild cognitive impairment (MCI), and examine the relationship of 25(OH)D and MCI with other clinical factors. One hundred and sixty-five diabetic patients were enrolled in this study. Among whom, 95 patients were considered as MCI [Montreal Cognitive Assessment score (MoCA) < 26] and the other 70 as no MCI (MoCA ≥ 26). Subjects were assessed clinically. Diabetic patients with MCI had a longer duration of DM, fewer years of education, elevated fasting blood glucose (FBG), resistant index (RI) of carotid, and lower levels of 25(OH)D {[17.35 (13.02–25.92) vs 28.00 (19.67–34.30)] ng/ml, P < 0.001}. The MoCA score was positively correlated with log10[25(OH)D], education year, and inversely correlated with duration of DM, history of hypertension, intima-media thickness (IMT), FBG, max-RI, and min-RI. Log10[25(OH)D] was positively correlated with MoCA score, and inversely correlated with IMT, in multivariate regression analysis adjusted for age, sex, and education year, 25(OH)D (β = 0.210, P = 0.003), history of hypertension (β = −0.191, P = 0.007), IMT (β = −0.194, P = 0.007), and FBG (β = −0.157, P = 0.026) independently predicted MoCA score. In conclusion, our results suggest that levels of serum 25(OH)D are inversely associated with the cognitive impairment in diabetic patients. Vitamin D may be a potential protective factor for cognitive impairment in patients with type 2 diabetes.